Source: Eur Respir Monogr 2014; 63: 155-167
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Rosario Menendez, Beatriz Montull, Raul Mendez. Antibiotic choice, route and duration: minimising the harm associated with antibiotics. Eur Respir Monogr 2014; 63: 155-167

Member's Comments

No comment yet.

Related content which might interest you: Reducing unnecessary antibiotic use and hospitalization in children with pneumonia Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019 Do empiric antibiotics delay appropriate antituberculosis medication in patients with active pulmonary tuberculosis? Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Frequency of side effects in antibiotic treatment for pneumonia Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007 Antibiotic resistance and clinical outcomes: the CAPNETZ experience Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Prescribing and guidelines: both must improve to combat antimicrobial resistance Source: Eur Respir J 2012; 39: 1050 Year: 2012 Prescribing and guidelines: both must improve to combat antimicrobial resistance Source: Eur Respir J 2011; 37: 9-11 Year: 2011 Antibiotic use in children: another increased risk of asthma? Source: Breathe 2009; 6: 64-65 Year: 2009 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Antibiotic use and misuse in the community: how to manage the problem Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Antibiotic prescribing in acute respiratory infections – are we following guidelines? Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006 Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones}, Source: Eur Respir J 2012; 40: 814-822 Year: 2012 Cost-effective antibiotic management of community acquired pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198 Year: 2004